Dare Bioscience, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Dare Bioscience, Inc. (DARE) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 578.45 thousand shares for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-27.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2020-03-27
- Dare Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2019-12-31 was 69.70K shares.
- Dare Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2019-09-30 was 191.91K shares.
- Dare Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2019-06-30 was 308.47K shares.
- Dare Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2019-03-31 was 8.36K shares.
- Dare Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2019 was 578.45K shares.
- Dare Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2017 was 30.48K shares, a 97.05% decline from fiscal 2016.
- Dare Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2016 was 1.03M shares, a 55.99% increase from fiscal 2015.
- Dare Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2015 was 661.70K shares, a 1897.77% increase from fiscal 2014.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2019-12-31 | 69.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | 261.61K shares derived: sum of 2 quarters · filed 2020-03-27 | 570.09K shares derived: sum of 3 quarters · filed 2020-03-27 | 578.45K shares 10-K · filed 2020-03-27 |
| 2019-09-30 | 191.91K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | 500.38K shares derived: sum of 2 quarters · filed 2019-11-12 | 508.75K shares 10-Q · filed 2019-11-12 | |
| 2019-06-30 | 308.47K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | 316.83K shares 10-Q · filed 2019-08-14 | ||
| 2019-03-31 | 8.36K shares 10-Q · filed 2019-05-14 | |||
| 2018-09-30 | 156.00 shares 10-Q · filed 2018-11-13 | |||
| 2017-12-31 | 15.92K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | 24.61K shares derived: sum of 2 quarters · filed 2018-03-28 | -28.16K shares derived: sum of 3 quarters · filed 2018-03-28 | 30.48K shares 10-K · filed 2018-03-28 |
| 2017-09-30 | 8.69K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | -44.08K shares derived: sum of 2 quarters · filed 2017-11-13 | 14.56K shares 10-Q · filed 2017-11-13 | 575.92K shares derived: sum of 4 quarters · filed 2017-11-13 |
| 2017-06-30 | -52.77K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | 5.86K shares 10-Q · filed 2017-08-14 | 567.23K shares derived: sum of 3 quarters · filed 2017-08-14 | 1.02M shares derived: sum of 4 quarters · filed 2017-08-14 |
| 2017-03-31 | 58.63K shares 10-Q · filed 2017-05-12 | 620.00K shares derived: sum of 2 quarters · filed 2017-06-13 | 1.07M shares derived: sum of 3 quarters · filed 2017-06-13 | 1.08M shares derived: sum of 4 quarters · filed 2017-06-13 |
| 2016-12-31 | 561.37K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-06-13 | 1.02M shares derived: sum of 2 quarters · filed 2017-06-13 | 1.02M shares derived: sum of 3 quarters · filed 2017-06-13 | 1.03M shares 10-K/A · filed 2017-06-13 |
| 2016-09-30 | 454.83K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | 460.43K shares derived: sum of 2 quarters · filed 2016-11-03 | 470.84K shares 10-Q · filed 2016-11-03 | 522.81K shares derived: sum of 4 quarters · filed 2016-11-03 |
| 2016-06-30 | 5.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | 16.01K shares 10-Q · filed 2016-08-04 | 67.97K shares derived: sum of 3 quarters · filed 2016-08-04 | 670.65K shares derived: sum of 4 quarters · filed 2016-08-04 |
| 2016-03-31 | 10.41K shares 10-Q · filed 2016-05-02 | 62.38K shares derived: sum of 2 quarters · filed 2016-05-02 | 665.06K shares derived: sum of 3 quarters · filed 2016-05-02 | 671.09K shares derived: sum of 4 quarters · filed 2016-05-02 |
| 2015-12-31 | 51.97K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | 654.65K shares derived: sum of 2 quarters · filed 2016-03-10 | 660.68K shares derived: sum of 3 quarters · filed 2016-03-10 | 661.70K shares 10-K · filed 2016-03-10 |
| 2015-09-30 | 602.68K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | 608.71K shares derived: sum of 2 quarters · filed 2015-11-16 | 609.74K shares 10-Q · filed 2015-11-16 | 609.74K shares derived: sum of 4 quarters · filed 2015-11-16 |
| 2015-06-30 | 6.03K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | 7.06K shares 10-Q · filed 2015-08-06 | 7.06K shares derived: sum of 3 quarters · filed 2015-08-06 | 26.89K shares derived: sum of 4 quarters · filed 2015-08-06 |
| 2015-03-31 | 1.02K shares 10-Q · filed 2015-05-06 | 1.02K shares derived: sum of 2 quarters · filed 2015-05-06 | 20.86K shares derived: sum of 3 quarters · filed 2015-05-06 | 27.95K shares derived: sum of 4 quarters · filed 2015-05-06 |
| 2014-12-31 | 3.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19 | 19.83K shares derived: sum of 2 quarters · filed 2015-03-19 | 26.93K shares derived: sum of 3 quarters · filed 2015-03-19 | 33.12K shares 10-K · filed 2015-03-19 |
| 2014-09-30 | 19.83K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | 26.92K shares derived: sum of 2 quarters · filed 2014-11-13 | 33.12K shares 10-Q · filed 2014-11-13 | |
| 2014-06-30 | 7.09K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | 13.29K shares 10-Q · filed 2014-08-12 | ||
| 2014-03-31 | 6.20K shares 10-Q · filed 2014-05-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |